Format
Sort by
Items per page

Send to

Choose Destination

Selected items

Items: 20

1.

Recent progress in the development of anthrax vaccines.

Kaur M, Bhatnagar R.

Recent Pat Biotechnol. 2011 Dec;5(3):148-59. Review.

PMID:
22360464
2.
3.

Anthrax vaccines.

Splino M, Patocka J, Prymula R, Chlibek R.

Ann Saudi Med. 2005 Mar-Apr;25(2):143-9. Review.

PMID:
15977694
4.

Anthrax vaccines: Pasteur to the present.

Scorpio A, Blank TE, Day WA, Chabot DJ.

Cell Mol Life Sci. 2006 Oct;63(19-20):2237-48.

PMID:
16964578
5.

Is new always better than old?: The development of human vaccines for anthrax.

Baillie LW.

Hum Vaccin. 2009 Dec;5(12):806-16. Epub 2009 Dec 9. Review.

PMID:
19786839
6.

Anthrax, toxins and vaccines: a 125-year journey targeting Bacillus anthracis.

Tournier JN, Ulrich RG, Quesnel-Hellmann A, Mohamadzadeh M, Stiles BG.

Expert Rev Anti Infect Ther. 2009 Mar;7(2):219-36. doi: 10.1586/14787210.7.2.219. Review.

PMID:
19254170
7.

Anthrax vaccines: past, present and future.

Turnbull PC.

Vaccine. 1991 Aug;9(8):533-9. Review.

PMID:
1771966
8.

It's in the genes! Human genetic diversity and the response to anthrax vaccines.

Ingram R, Baillie L.

Expert Rev Vaccines. 2012 Jun;11(6):633-5. doi: 10.1586/erv.12.41. No abstract available.

PMID:
22873120
9.

Killed but metabolically active Bacillus anthracis vaccines induce broad and protective immunity against anthrax.

Skoble J, Beaber JW, Gao Y, Lovchik JA, Sower LE, Liu W, Luckett W, Peterson JW, Calendar R, Portnoy DA, Lyons CR, Dubensky TW Jr.

Infect Immun. 2009 Apr;77(4):1649-63. doi: 10.1128/IAI.00530-08. Epub 2009 Jan 21.

10.

Advances in the development of next-generation anthrax vaccines.

Friedlander AM, Little SF.

Vaccine. 2009 Nov 5;27 Suppl 4:D28-32. doi: 10.1016/j.vaccine.2009.08.102. Review.

PMID:
19837282
11.

Molecular basis for improved anthrax vaccines.

Brey RN.

Adv Drug Deliv Rev. 2005 Jun 17;57(9):1266-92. Epub 2005 Apr 21. Review.

PMID:
15935874
12.

Vaccines for preventing anthrax.

Donegan S, Bellamy R, Gamble CL.

Cochrane Database Syst Rev. 2009 Apr 15;(2):CD006403. doi: 10.1002/14651858.CD006403.pub2. Review.

PMID:
19370633
13.

Stevens-Johnson syndrome after immunization with smallpox, anthrax, and tetanus vaccines.

Chopra A, Drage LA, Hanson EM, Touchet NL.

Mayo Clin Proc. 2004 Sep;79(9):1193-6.

PMID:
15357044
14.

Vaccines: countering anthrax: vaccines and immunoglobulins.

Grabenstein JD.

Clin Infect Dis. 2008 Jan 1;46(1):129-36. doi: 10.1086/523578. Review.

PMID:
18171228
15.

Feasibility of the use of ELISA in an immunogenicity-based potency test of anthrax vaccines.

Jiménez-Alberto A, Parreiras P, Castelán-Vega J, Sirota L, Arciniega J.

Biologicals. 2011 Jul;39(4):236-41. doi: 10.1016/j.biologicals.2011.05.001. Epub 2011 Jun 12.

PMID:
21664832
16.

Anthrax vaccines: a development update.

Little SF.

BioDrugs. 2005;19(4):233-45. Review.

PMID:
16128606
17.

Evaluation of combinatorial vaccines against anthrax and plague in a murine model.

DuBois AB, Freytag LC, Clements JD.

Vaccine. 2007 Jun 11;25(24):4747-54. Epub 2007 Apr 20.

18.

Key roles of dendritic cells in lung infection and improving anthrax vaccines.

Tournier JN, Mohamadzadeh M.

Trends Mol Med. 2010 Jul;16(7):303-12. doi: 10.1016/j.molmed.2010.04.006. Epub 2010 Jun 1. Review.

PMID:
20554248
19.

Vaccines and bioterrorism: smallpox and anthrax.

Kimmel SR, Mahoney MC, Zimmerman RK.

J Fam Pract. 2003 Jan;52(1 Suppl):S56-61. Review.

PMID:
12556279
20.

Attenuated nontoxinogenic and nonencapsulated recombinant Bacillus anthracis spore vaccines protect against anthrax.

Cohen S, Mendelson I, Altboum Z, Kobiler D, Elhanany E, Bino T, Leitner M, Inbar I, Rosenberg H, Gozes Y, Barak R, Fisher M, Kronman C, Velan B, Shafferman A.

Infect Immun. 2000 Aug;68(8):4549-58.

Supplemental Content

Support Center